Literature DB >> 9194521

Sulfation and sulfotransferases 5: the importance of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) in the regulation of sulfation.

C D Klaassen1, J W Boles.   

Abstract

Sulfation is the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to a substrate that is catalyzed by a family of sulfotransferase enzymes. Many different endogenous and xenobiotic molecules are substrates for the sulfotransferases; sulfation affects many different physiological processes, including: 1) deactivation and bioactivation of xenobiotics, 2) inactivation of hormones and catecholamines, 3) structure and function of macromolecules, and 4) elimination of end products of catabolism. PAPS is the obligate cosubstrate that is synthesized in tissues to make available an "activated form" of sulfate for the sulfation reaction. PAPS participation in the reaction is dependent on its availability, which in turn is dependent on its synthesis, degradation, and ultimately its utilization in the sulfation reaction itself. PAPS synthesis is dependent on the availability of sulfate and on the activity of the two enzymes of its synthesis, ATP-sulfurylase and APS-kinase. Although the kinetic properties of these two enzymes are well described, their in vivo regulation is not fully understood. Sulfation is a high-affinity, low-capacity enzymatic process in which the entire liver content of PAPS can be consumed in less than 2 min. ATP-sulfurylase and APS-kinase can rapidly synthesize additional PAPS. The low capacity of sulfation in rats is due to the limited availability of sulfate, whereas in mice the sulfotransferases appear to limit sulfation capacity. Sulfation rates are not readily enhanced, but they can be decreased. 2,6-Dichloro-4-nitrophenol inhibits phenolsulfotransferases, but not hydroxysteroid-sulfotransferases. However, the sulfation of phenols and hydroxysteroids can be decreased by factors that decrease sulfate availability such as a low-sulfate diet, other xenobiotics that are sulfated, and molybdate, which inhibits sulfate intestinal absorption, renal reabsorption, and sulfate incorporation into PAPS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194521     DOI: 10.1096/fasebj.11.6.9194521

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  87 in total

1.  Mechanistic studies of beta-arylsulfotransferase IV.

Authors:  Eli Chapman; Marian C Bryan; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

2.  Two Golgi-resident 3'-Phosphoadenosine 5'-phosphosulfate transporters play distinct roles in heparan sulfate modifications and embryonic and larval development in Caenorhabditis elegans.

Authors:  Katsufumi Dejima; Daisuke Murata; Souhei Mizuguchi; Kazuko H Nomura; Tomomi Izumikawa; Hiroshi Kitagawa; Keiko Gengyo-Ando; Sawako Yoshina; Tomomi Ichimiya; Shoko Nishihara; Shohei Mitani; Kazuya Nomura
Journal:  J Biol Chem       Date:  2010-06-06       Impact factor: 5.157

Review 3.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

Review 4.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

Review 5.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

6.  Potent inhibition of human sulfotransferase 1A1 by 17α-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity.

Authors:  Katie Jo Rohn; Ian T Cook; Thomas S Leyh; Susan A Kadlubar; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2012-05-16       Impact factor: 3.922

7.  Identification of sulfation sites of metabolites and prediction of the compounds' biological effects.

Authors:  Lin Yi; Joe Dratter; Chao Wang; Jon A Tunge; Heather Desaire
Journal:  Anal Bioanal Chem       Date:  2006-05-25       Impact factor: 4.142

8.  High accuracy in silico sulfotransferase models.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

9.  Pharmacogenetics of SULT1A1.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

10.  Structure of the two-domain hexameric APS kinase from Thiobacillus denitrificans: structural basis for the absence of ATP sulfurylase activity.

Authors:  Sean C Gay; Irwin H Segel; Andrew J Fisher
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.